Ying T - Search Results

1

Ying T, Wen Y, Dimitrov DS. Ying T, et al. Emerg Microbes Infect. 2017 Apr 26;6(4):e25. doi: 10.1038/emi.2017.22. Emerg Microbes Infect. 2017. PMID: 28442753 Free PMC article. No abstract available.

2

Soluble monomeric IgG1 Fc.

Ying T, Chen W, Gong R, Feng Y, Dimitrov DS. Ying T, et al. J Biol Chem. 2012 Jun 1;287(23):19399-408. doi: 10.1074/jbc.M112.368647. Epub 2012 Apr 19. J Biol Chem. 2012. PMID: 22518843 Free PMC article.

3

Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn.

Gong R, Wang Y, Ying T, Dimitrov DS. Gong R, et al. Among authors: ying t. PLoS One. 2012;7(8):e42288. doi: 10.1371/journal.pone.0042288. Epub 2012 Aug 7. PLoS One. 2012. PMID: 22879932 Free PMC article.

4

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.

Chen W, Ying T, Dimitrov DS. Chen W, et al. Among authors: ying t. Expert Opin Biol Ther. 2013 May;13(5):657-71. doi: 10.1517/14712598.2013.761969. Epub 2013 Jan 7. Expert Opin Biol Ther. 2013. PMID: 23293858 Free PMC article. Review.

5

N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance.

Gong R, Wang Y, Ying T, Feng Y, Streaker E, Prabakaran P, Dimitrov DS. Gong R, et al. Among authors: ying t. Mol Pharm. 2013 Jul 1;10(7):2642-52. doi: 10.1021/mp400075f. Epub 2013 May 29. Mol Pharm. 2013. PMID: 23641816 Free PMC article.

6

Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains.

Chen W, Gong R, Ying T, Prabakaran P, Zhu Z, Feng Y, Dimitrov DS. Chen W, et al. Among authors: ying t. Curr Drug Discov Technol. 2014 Mar;11(1):28-40. doi: 10.2174/15701638113109990032. Curr Drug Discov Technol. 2014. PMID: 23863097 Free PMC article. Review.

7

Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.

Ying T, Chen W, Feng Y, Wang Y, Gong R, Dimitrov DS. Ying T, et al. J Biol Chem. 2013 Aug 30;288(35):25154-25164. doi: 10.1074/jbc.M113.484154. Epub 2013 Jul 18. J Biol Chem. 2013. PMID: 23867459 Free PMC article.

8

Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Chen W, Feng Y, Prabakaran P, Ying T, Wang Y, Sun J, Macedo CD, Zhu Z, He Y, Polonis VR, Dimitrov DS. Chen W, et al. Among authors: ying t. J Virol. 2014 Jan;88(2):1125-39. doi: 10.1128/JVI.02566-13. Epub 2013 Nov 6. J Virol. 2014. PMID: 24198429 Free PMC article.

9

Interactions of IgG1 CH2 and CH3 Domains with FcRn.

Ying T, Ju TW, Wang Y, Prabakaran P, Dimitrov DS. Ying T, et al. Front Immunol. 2014 Apr 2;5:146. doi: 10.3389/fimmu.2014.00146. eCollection 2014. Front Immunol. 2014. PMID: 24765095 Free PMC article.

10

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Ying T, Du L, Ju TW, Prabakaran P, Lau CC, Lu L, Liu Q, Wang L, Feng Y, Wang Y, Zheng BJ, Yuen KY, Jiang S, Dimitrov DS. Ying T, et al. J Virol. 2014 Jul;88(14):7796-805. doi: 10.1128/JVI.00912-14. Epub 2014 Apr 30. J Virol. 2014. PMID: 24789777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page